{"id":780415,"date":"2021-09-30T08:02:44","date_gmt":"2021-09-30T15:02:44","guid":{"rendered":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/?post_type=msr-blog-post&#038;p=780415"},"modified":"2022-01-31T08:26:20","modified_gmt":"2022-01-31T16:26:20","slug":"covid-19-outcomes-among-hospitalized-men-with-or-without-exposure-to-alpha-1-adrenergic-receptor-blocking-agents","status":"publish","type":"msr-blog-post","link":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/articles\/covid-19-outcomes-among-hospitalized-men-with-or-without-exposure-to-alpha-1-adrenergic-receptor-blocking-agents\/","title":{"rendered":"COVID-19 outcomes among hospitalized men with or without exposure to alpha-1-adrenergic receptor blocking agents"},"content":{"rendered":"<p>Alpha-1-adrenergic receptor antagonists (\u03b11-blockers) can abrogate pro-inflammatory cytokines and may improve outcomes among patients with respiratory infections. Repurposing readily available drugs such as \u03b11-blockers could augment the medical response to the COVID-19 pandemic.<\/p>\n<p><a href=\"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/wp-content\/uploads\/2021\/09\/COVID-19-outcomes-among-hospitalized-men-with-or-without-exposure-to-alpha-1-adrenergic-receptor-blocking-agents.pdf\">COVID-19 outcomes among hospitalized men with or without exposure to alpha-1-adrenergic receptor blocking agents<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alpha-1-adrenergic receptor antagonists (\u03b11-blockers) can abrogate pro-inflammatory cytokines and may improve outcomes among patients with respiratory infections. Repurposing readily available drugs such as \u03b11-blockers could augment the medical response to the COVID-19 pandemic. COVID-19 outcomes among hospitalized men with or without exposure to alpha-1-adrenergic receptor blocking agents<\/p>\n","protected":false},"author":37625,"featured_media":0,"template":"","meta":{"msr-url-field":"","msr-podcast-episode":"","msrModifiedDate":"","msrModifiedDateEnabled":false,"ep_exclude_from_search":false,"_classifai_error":"","msr-content-parent":669339,"msr_hide_image_in_river":0,"footnotes":""},"research-area":[],"msr-locale":[268875],"msr-post-option":[],"class_list":["post-780415","msr-blog-post","type-msr-blog-post","status-publish","hentry","msr-locale-en_us"],"msr_assoc_parent":{"id":669339,"type":"group"},"_links":{"self":[{"href":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/wp-json\/wp\/v2\/msr-blog-post\/780415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/wp-json\/wp\/v2\/msr-blog-post"}],"about":[{"href":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/wp-json\/wp\/v2\/types\/msr-blog-post"}],"author":[{"embeddable":true,"href":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/wp-json\/wp\/v2\/users\/37625"}],"version-history":[{"count":4,"href":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/wp-json\/wp\/v2\/msr-blog-post\/780415\/revisions"}],"predecessor-version":[{"id":816847,"href":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/wp-json\/wp\/v2\/msr-blog-post\/780415\/revisions\/816847"}],"wp:attachment":[{"href":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/wp-json\/wp\/v2\/media?parent=780415"}],"wp:term":[{"taxonomy":"msr-research-area","embeddable":true,"href":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/wp-json\/wp\/v2\/research-area?post=780415"},{"taxonomy":"msr-locale","embeddable":true,"href":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/wp-json\/wp\/v2\/msr-locale?post=780415"},{"taxonomy":"msr-post-option","embeddable":true,"href":"https:\/\/cm-edgetun.pages.dev\/en-us\/research\/wp-json\/wp\/v2\/msr-post-option?post=780415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}